Kevin Warshs Potential Fed Regime Change Could Reshape Wall Streets Market Plumbing The Mandalorian and Grogu Draws Strong Early Praise Could Reinvigorate Star Wars Franchise Andhra Pradesh Targets MSMELed Growth with Industrial Parks 100 Unicorn Goal Historical Fed Funds Rate A 72Year Perspective 19542026 Michael Price Advocates Contrarian Approach for Navigating Market Volatility UK Politicians Urged to Shift Focus from Bond Markets to Bank of England Says Economist Identiv Inc INVE Q1 2026 Earnings EPS Falls Short of Estimates as Company Navigates Transition NetSol Technologies NTWK Q1 2026 Earnings Profitability Surprise Drives Positive Momentum SCM Q1 2026 Earnings Slight EPS Miss Amid Stable Portfolio Performance VABK Q1 2026 Earnings Reported EPS of 097 Drives Positive Stock Movement Catheter Precision VTAK Q1 2025 Earnings Significant EPS Miss as Stock Rises Amid Strategic Progress IDEX Corporation Q1 2026 Earnings Strong EPS Beat Drives Stock Uptick PagerDuty Inc PD Rallies 327 as Stock Nears Key Resistance Level Sabine Royalty Trust SBR Holds Steady Near MidRange as Energy Royalty Sector Consolidates Invest Green Acquisition Rights IGACR Holds Steady at 015 in Quiet Trading Enova International Inc ENVA Pulls Back 21 Support Test Could Define NearTerm Trend LiveRamp Holdings RAMP Slight Dip Amid Consolidation Near Resistance Q1 GDP Advance Estimate Slides to 20 Missing Market Expectations GOODO Q1 2026 Earnings Strong EPS Surprise of 5686 Boosts Investor Confidence Sally Beauty Holdings SBH Edges Higher Amid Consolidation Near Support GEN Q1 2026 Earnings EPS Beats Estimates by 201 Despite Modest Stock Decline Kadant Inc KAI Q1 2026 Earnings Strong EPS Beat Despite Revenue Uncertainty Chime Financial Inc CHYM Q1 2026 Earnings Robust EPS Beat Defies Market Skepticism APH Q1 2026 Earnings EPS Smashes Estimates Amid Strong Demand Shares Surge UPXI Q1 2026 Earnings Significant EPS Miss Drives Stock Decline Legato Merger Corp III LEGT Q1 2026 Earnings SPAC Reports Positive EPS Amid Quiet Quarter LCTX Q1 2026 Earnings Widerthanexpected loss as clinicalstage biotech advances pipeline